Alembic Pharmaceuticals Limited (APLLTD):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Alembic Pharmaceuticals Limited (APLLTD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH51841FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Alembic Pharmaceuticals Limited (Alembic Pharma) is an integrated pharmaceutical company. It undertakes the development, manufacturing and marketing of pharmaceutical products, active pharmaceutical ingredients and intermediates. The company offers products and services in five divisions, namely, active pharmaceutical ingredients, bulk pharma chemicals, formulations, herbal nutraceuticals, veterinary and contract research services. Alembic Pharma holds expertise in the Macrolides segment of anti-infective drugs. It offers active pharmaceutical ingredients and other drugs in the therapeutic areas of anti infectives, cardio vascular, musculoskeletol, erectile dysfunction and gastro intestinal. The company operates two manufacturing facilities in Vadodara, Gujarat and Baddi, Himachal Pradesh. Alembic Pharmaceuticals is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Limited Key Recent Developments

Oct 29, 2013: Indian Department of Pharmaceuticals Rejects Review Applications Over Fixed Ceiling Price Of Drugs
Oct 25, 2013: Alembic Pharmaceuticals announces for Quarter ended 3oth June 2013
Sep 13, 2013: Alembic Appoints R. C. Saxena as Non-Executive Independent Director
Aug 07, 2013: Alembic Pharmaceuticals Limited announces for Quarter ended 30th June 2013
May 02, 2013: Alembic Pharma Reports Revenue Of INR15.3 Billion In Fiscal 2013

This comprehensive SWOT profile of Alembic Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alembic Pharmaceuticals Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Alembic Pharmaceuticals Limited – Key Information
Alembic Pharmaceuticals Limited – Overview
Alembic Pharmaceuticals Limited – Key Employees
Alembic Pharmaceuticals Limited – Key Employee Biographies
Alembic Pharmaceuticals Limited – Key Operational Heads
Alembic Pharmaceuticals Limited – Major Products and Services
Alembic Pharmaceuticals Limited – History
Alembic Pharmaceuticals Limited – Company Statement
Alembic Pharmaceuticals Limited – Locations And Subsidiaries
Alembic Pharmaceuticals Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Alembic Pharmaceuticals Limited – Business Description
Alembic Pharmaceuticals Limited – Corporate Strategy
Alembic Pharmaceuticals Limited – SWOT Analysis
SWOT Analysis – Overview
Alembic Pharmaceuticals Limited – Strengths
Alembic Pharmaceuticals Limited – Weaknesses
Alembic Pharmaceuticals Limited – Opportunities
Alembic Pharmaceuticals Limited – Threats
Alembic Pharmaceuticals Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Alembic Pharmaceuticals Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Alembic Pharmaceuticals Limited, Key Information
Alembic Pharmaceuticals Limited, Key Ratios
Alembic Pharmaceuticals Limited, Share Data
Alembic Pharmaceuticals Limited, Major Products and Services
Alembic Pharmaceuticals Limited, History
Alembic Pharmaceuticals Limited, Key Employees
Alembic Pharmaceuticals Limited, Key Employee Biographies
Alembic Pharmaceuticals Limited, Key Operational Heads
Alembic Pharmaceuticals Limited, Other Locations
Alembic Pharmaceuticals Limited, Subsidiaries
Alembic Pharmaceuticals Limited, Key Manufacturing facilities
Alembic Pharmaceuticals Limited, Key Competitors
Alembic Pharmaceuticals Limited, SWOT Analysis
Alembic Pharmaceuticals Limited, Ratios based on current share price
Alembic Pharmaceuticals Limited, Annual Ratios
Alembic Pharmaceuticals Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Alembic Pharmaceuticals Limited, Performance Chart
Alembic Pharmaceuticals Limited, Ratio Charts

★海外企業調査レポート[Alembic Pharmaceuticals Limited (APLLTD):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pier 1 Imports, Inc.:企業の戦略・SWOT・財務分析
    SummaryPier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • DCC Plc (DCC):石油・ガス:M&Aディール及び事業提携情報
    Summary DCC Plc (DCC) is a diversified company that offers international sales, marketing, distribution and business support services. The company operates through its business divisions such as LPG, retail, and oil, healthcare and technology. Its LPG business markets liquefied petroleum gas and nat …
  • Asahi Group Holdings Ltd:戦略・SWOT・企業財務分析
    Asahi Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Asahi Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Renewable Energy Holdings plc (REH):企業の財務及び戦略的SWOT分析
    Summary Renewable Energy Holdings plc (REH) is a renewable energy company that operates wind assets. The company carries out activities such as development of green-field project opportunities; acquisition of operating assets with upside potential; and acquisition of late stage project development o …
  • A/S Mons Bank (MNBA):企業の財務及び戦略的SWOT分析
    Summary A/S Mons Bank (Mons Bank) is a financial and banking service provider that provides private, investment, and profession banking services. The bank provides counselling, pension info, compensation tax, and insurance services. Mons Bank offers insurance for life, loss of earning capacity, crit …
  • Deutsche Lufthansa AG:企業の戦略・SWOT・財務分析
    SummaryDeutsche Lufthansa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • OXEA Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OXEA Group Mergers and Acquisit …
  • Infineon Technologies AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Infineon Technologies AG Merger …
  • Coca-Cola Bottling Co. Consolidated (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Bottling Co. Consolidated (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Albertson’s LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Albertson's LLC Mergers and Acq …
  • Taminco N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Taminco N.V. Mergers and Acquis …
  • Electrical Geodesics, Inc. (EGI):(医療機器分野)企業M&A及び提携動向
    Summary Electrical Geodesics, Inc. (EGI) is a medical device company. The company operates through divisions such as clinical division, research division and neuroinformatics division. It offers clinical products such as Geodesic EEG system 400 series, Geodesic EEG system 300, Geodesic EEG mobile 10 …
  • Meridian Bioscience, Inc. (VIVO):企業の財務及び戦略的SWOT分析
    Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Indian Bank:企業の戦略・SWOT・財務情報
    Indian Bank - Strategy, SWOT and Corporate Finance Report Summary Indian Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Manipal Education and Medical Group International India Pvt., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Manipal Education and Medical G …
  • Graphic Packaging International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Graphic Packaging International …
  • Morcher Gmbh:企業の製品パイプライン分析2018
    Summary Morcher Gmbh (Morcher) is a medical device company that develops, manufactures, and distributes implants for cataract surgery. The company’s products include capsular tension rings, eyejet ctr - preloaded capsular tension rings, cionni rings for scleral fixation, capsular segment for scleral …
  • Ramco-Gershenson Properties Trust:企業のM&A・事業提携・投資動向
    Ramco-Gershenson Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ramco-Gershenson Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • China Netcom Technology Holdings Limited (8071):企業財務及び戦略的SWOT分析
    Summary China Netcom Technology Holdings Limited (CNTHL), formerly China Metal Resources Holdings Limited is a technology consulting company that provides information technology consultancy services. The company's activities include trading of computer hardware and software, the provision of lottery …
  • Citigold Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Citigold Corporation Limited Me …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆